Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 2003

View Archived Issues

BMS researchers describe new metalloproteinase inhibitors and their use

AxyS and Cytovia patent novel caspase activators for use as antitumor agents

New 5-HT1A antagonist/5-HT reuptake inhibitor identified at GSK

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Merck identifies estrogen ERalpha modulators useful in osteoporosis, cancer, etc.

Wyeth scientists claim novel estrogen receptor modulators

Imidazoline antidiabetic agent NNC-77-0020 modulates pancreatic hormone secretion

Novel phospholipid derivative of indomethacin shows potential in Alzheimer's disease Rx

SBIR grant aids search for longer acting adenosine A2A agonists

Approvable letter for Orthovisc

German approval for Leuprogel one-month depot product

Faulding changes name to Mayne Pharma

Rolling NDA submission continues for Onco TCS

Enhanced antiinflammatory effects of NO-releasing statins reported by NicOx

Inologic makes good progress in INO-4995 development

Positive results for icatibant in treatment of refractory ascites in liver cirrhosis

La Jolla discovers inhibitors of SSAO

Maxim licenses MX-90745 series to Myriad

Doripenem active in vitro against P. aeruginosa and B. cepacia

Peptech and Biosceptre enter joint venture agreement

Xcytrin granted fast track status for brain metastases in NSCLC patients

RVT 202 study of Reverset completes enrollment

Sepracor reports phase III program results for Xopenex HFA MDI

Skyepharma and Novartis to develop new COPD and asthma treatment

Stressgen and Roche restructure HspE7 alliance

Telcyta awarded fast track status for third-line therapy of NSCLC

Noncalcemic vitamin D analogue potently suppresses PTH in renal failure

In vivo efficacy of drugs targeting tumor vasculature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...